Eszopiclone: The Evolution of the ‘Z-Drug’

Eszopiclone is the active (S)-enantiomer of Zopiclone, the medication we explored in the previous installment. In the world of pharmacology, an enantiomer is a “mirror-image” version of a molecule; in this case, the (S)-version is responsible for almost all the sleep-inducing benefits, while the (R)-version primarily adds to the side-effect burden. By isolating the active half, scientists created Eszopiclone—a more potent, refined hypnotic that has become a favorite in Indian private healthcare for treating long-term insomnia. Marketed under brands like Fulnite and Eszop, it offers a longer window of sleep than Zolpidem but requires even stricter adherence to safety protocols due to its increased potency.

This eighteenth installment provides an exhaustive analysis of Eszopiclone in India for 2026.

---

1. Substance Profile & Classification

• Generic Name: Eszopiclone
• Chemical Class: Cyclopyrrolone ((S)-enantiomer of Zopiclone)
• Therapeutic Class: Hypnotic
• Indian Legal Status:
  • Schedule H1 Drug (2026): Along with its parent drug Zopiclone, Eszopiclone is classified under Schedule H1 in India as of April 2026. This requires physical prescription verification and the maintenance of a rigorous sales register by the pharmacist.
  • Prescription Policy: It is strictly prohibited for over-the-counter sale. In 2026, regulators have flagged Eszopiclone for high “diversion potential” among the urban middle class.

---

2. Market Availability and Pricing in India (May 2026)

Eszopiclone is available in 1mg, 2mg, and 3mg tablets, allowing for precise dose titration.

A. PMBJP (Jan Aushadhi Kendra) Availability

As of May 2026, Eszopiclone is NOT available in the Jan Aushadhi unbranded list. The PMBJP basket focused on older generics to keep costs at the absolute minimum.

B. Branded Market Prices (Commercial Sector)

Branded Eszopiclone is positioned as a “premium” sleep aid. In 2026, many private psychiatrists prefer it over Zopiclone for its cleaner recovery profile.

Brand Name	Manufacturer	Strength	Approx. Market Price (INR)
Fulnite	Sun Pharma	2mg (10 Tabs)	₹185.00
Fulnite-3	Sun Pharma	3mg (10 Tabs)	₹235.00
Eszop	Intas Pharmaceuticals	2mg (10 Tabs)	₹168.00
Hypnite	Consern Pharma	2mg (10 Tabs)	₹110.00
Zunestar	Unichem	3mg (10 Tabs)	₹210.00
Zopipure	Samok Overseas	2mg (10 Tabs)	₹145.00

[!NOTE] Market Position: Eszopiclone is significantly more expensive than Zolpidem, reflecting its positioning as a specialized psychiatric tool for chronic insomnia management in urban India.

[!NOTE] 3mg of Eszopiclone is clinically equivalent to approximately 7.5mg of racemic Zopiclone but is often reported by patients to have a slightly cleaner recovery profile.

---

3. Clinical Pharmacology: The Potency of the (S)-Isomer

Mechanism of Action

Eszopiclone acts as a GABA-A receptor modulator.

• Targeted Action: It binds with high affinity to the GABA-A receptor complex, enhancing the inhibitory effect of GABA.
• Sleep Maintenance: Because it has a slightly longer half-life than Zolpidem, it is particularly effective for “Maintenance Insomnia”—patients who can fall asleep but wake up at 3:00 AM and cannot get back to sleep.

Pharmacokinetics

• Potency: 2x more potent than racemic Zopiclone.
• Half-life: Approximately 6 hours in healthy adults.
• Elderly Caution: In patients over 65, the half-life can extend to 9 hours, significantly increasing the risk of falls and morning confusion.
• Metabolism: Metabolized in the liver (CYP3A4 and CYP2C8).

---

4. Chronic Insomnia: The 6-Month Context

One reason for Eszopiclone’s popularity in India is that it was one of the first Z-drugs to be studied for long-term use.

• Extended Use: Clinical trials have shown that Eszopiclone can be used for up to 6 months without a significant loss of effectiveness (tolerance), unlike benzodiazepines which often lose their power in 2-4 weeks.
• Caveat: Despite these studies, Indian psychiatric guidelines still recommend “drug holidays” and using the lowest possible dose to avoid psychological dependence.

---

5. Euphoria and Misuse: The “Clean” Sedation

Euphoria Profile

• Anxiolytic Effect: Because Eszopiclone is more potent, some users experience a mild sense of euphoria or “well-being” shortly before falling asleep.
• The “Vivid Dream” State: Some users in India report exceptionally vivid or strange dreams, which can become a “draw” for recreational misuse.

Misuse Trends in India

1. Professional “Burnout” Management: Misuse is most common among the high-income urban workforce in India who use Eszopiclone to “force-reset” their sleep cycles after international travel or chronic overwork.
2. Alcohol Combination: Similar to other Z-drugs, mixing Eszopiclone with alcohol is a dangerous trend in the “late-night party” culture, leading to severe respiratory depression and total amnesia.

---

6. Hallmark Side Effects: The Bitter Legacy

While Eszopiclone is “refined,” it still carries the genetic legacy of Zopiclone.

• Bitter Taste: About 30% of patients report an unpleasant, bitter, or metallic taste. However, many Indian clinicians find that the 1mg and 2mg doses of Eszopiclone cause less severe taste distortion than the standard 7.5mg Zopiclone dose.
• Next-Day Somnolence: Due to its 6-hour half-life, users who do not get a full 8 hours of sleep often feel “heavy-headed” the next morning.

---

7. Toxicity and Overdose

Overdose Signs

• Profound Sedation (Cannot be woken).
• Ataxia (Inability to walk straight).
• Hypotension (Dangerously low blood pressure).

Emergency Action: Call 14446 or the AIIMS Poison Control Center. Hospital treatment involves monitoring the heart and lungs and may include Flumazenil if the sedation is life-threatening.

---

8. Legal Penalties and 2026 Enforcement

• Schedule H1 Audits: In 2026, the CDSCO has implemented “randomized digital audits” of pharmacy stocks. Any pharmacy selling Eszopiclone without a corresponding prescription record in the H1 register faces immediate closure.
• Illegal Export: Under the NDPS framework and the 2026 amendments, exporting Eszopiclone without an international permit is a non-bailable criminal offense.

---

9. Addiction and Recovery

Dependency on Eszopiclone is often psychological—the patient feels they “cannot function” without the pill.

• Rebound Effect: Stopping the drug after months of use can lead to extreme anxiety and “rebound insomnia” for 3-5 days.
• Recovery: Successful recovery in India involves transitioning to “Sleep Hygiene” protocols and cognitive behavioral therapy for insomnia (CBT-I).

Resources for Help in India

• National Drug De-addiction Helpline: 14446
• NIMHANS: Bangalore (Center of Excellence for Sleep Disorders).
• Fortis Mental Health: (Private specialized care for sleep architecture).

---

10. Harm Reduction Strategies

• The “8-Hour” Commitment: Never take Eszopiclone (especially the 2mg or 3mg dose) unless you are guaranteed at least 8 hours of undisturbed sleep.
• Taste Mitigation: Use a tongue scraper and citrus-based mouthwash in the morning to combat the metallic aftertaste.
• Elderly Dosing: For those over 65 in India, the dose should NEVER exceed 2mg to prevent nighttime falls and fractures.

---

Next in the Series: Part 19: Phenobarbital – The Ancient Anticonvulsant and the Barbiturate Legacy

Disclaimer: This series is for educational and harm-reduction purposes only. Eszopiclone is a powerful hypnotic that requires careful medical supervision. Never share your prescription or use this medication with alcohol.